摘要
近年来,扩张型心肌病(DCM)的治疗取得了长足的进步。临床治疗方面第3代β受体阻滞剂的问世显著降低了DCM患者的病死率;免疫干预与免疫吸附已取得了显著的疗效;心脏再同步化治疗明显改善了DCM患者的心功能,已成为DCM患者的一项辅助治疗手段;心脏移植是终末期DCM患者的有效治疗手段之一。基础研究方面基因治疗与细胞移植是目前研究的热点,有望为DCM患者开创新的治疗途径。
The treatment of dilated cardiomyopathy （DCM）has made great progress in recent years. The third generation of β-receptor blocker can significandy decrease the case fatality of DCM ; Immunologic intervention and immune absorbption had achieved obviouse efficacy. cardiac resynchronization therapy can obviously improve the cardiac function, which has been a assisted therapeutic methods for DCM. Heart transplantation has become one of effective means to treat DCM in the end stage. Gene therapy and cell transplantation in preclinical study is the hot spot at present,which will explore a new therapeutic methods for patients with DCM.
出处
《医学综述》
2008年第10期1530-1532,共3页
Medical Recapitulate
关键词
扩张型心肌病
心力衰竭
治疗
Dilated cardiomyopathy
Heart failure
Treatment
